triamterene has been researched along with Familial Hypokalemic Periodic Paralysis in 3 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 46-year-old man with hypokalemic periodic paralysis (HypoPP) and diabetes mellitus (DM) had worsened muscle weakness after acetazolamide (ACZ) treatment." | 7.71 | Acetazolamide-induced muscle weakness in hypokalemic periodic paralysis. ( Ichikawa, Y; Igarashi, O; Ikeda, K; Iwasaki, Y; Kinoshita, M; Satoyoshi, E; Yabuki, D, 2002) |
| "A 46-year-old man with hypokalemic periodic paralysis (HypoPP) and diabetes mellitus (DM) had worsened muscle weakness after acetazolamide (ACZ) treatment." | 3.71 | Acetazolamide-induced muscle weakness in hypokalemic periodic paralysis. ( Ichikawa, Y; Igarashi, O; Ikeda, K; Iwasaki, Y; Kinoshita, M; Satoyoshi, E; Yabuki, D, 2002) |
| "Primary hypokalemic periodic paralysis is an autosomal dominant skeletal muscle channelopathy." | 1.42 | The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis. ( He, F; Huang, H; Jiang, Y; Ke, Q; Lu, L; Qi, M; Weng, C; Yi, X; Yu, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ke, Q | 1 |
| He, F | 1 |
| Lu, L | 1 |
| Yu, P | 1 |
| Jiang, Y | 1 |
| Weng, C | 1 |
| Huang, H | 1 |
| Yi, X | 1 |
| Qi, M | 1 |
| Ikeda, K | 1 |
| Iwasaki, Y | 1 |
| Kinoshita, M | 1 |
| Yabuki, D | 1 |
| Igarashi, O | 1 |
| Ichikawa, Y | 1 |
| Satoyoshi, E | 1 |
| Nemoto, H | 1 |
| Kurihara, T | 1 |
1 review available for triamterene and Familial Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
[Periodic paralysis secondary to urinary or gastrointestinal potassium loss].
Topics: Animals; Diagnosis, Differential; Diarrhea; Digestive System; Drug Therapy, Combination; Humans; Hyp | 2001 |
2 other studies available for triamterene and Familial Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis.
Topics: Acetazolamide; Adult; Asian People; Calcium Channels; Calcium Channels, L-Type; Female; Humans; Hypo | 2015 |
Acetazolamide-induced muscle weakness in hypokalemic periodic paralysis.
Topics: Acetazolamide; Acidosis, Renal Tubular; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Di | 2002 |